…Low-dose topiramate appears to be as effective as the atypical antipsychotic agent risperidone in controlling behavioural disturbances in AD patients, according to the results of a double-blind trial (Mowla & Pani. J Clin Psychopharmacol 2010; 30: 40-43). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
The U.S. Food and Drug Administration has issued a safety announcement that the risk of progressive multifocal leukoencephalopathy (PML) increases with the number of infusions received of Tysabri (natalizumab) (www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm199872.htm). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newslet…
…A retrospective cohort study has reported that a withdrawal syndrome is common in PD patients who discontinue treatment with a dopamine agonist (Rabinak & Nirenberg. Arch Neurol 2010; 67: 58-63). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
…Ginkgo biloba is often taken by older adults to prevent cognitive decline but the herbal product appears to be ineffective, according to the Gingko Evaluation of Memory (GEM) study (Snitz et al. JAMA 2009; 302: 2663-2670). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
…Combination therapy may be an effective approach in patients with psychotic depression, according to the results of the STOP-PD trial (Meyers et al. Arch Gen Psychiatry 2009; 66: 838-847). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…